ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

APTCF Advanced Proteome Therapeutics Corporation (CE)

0.0002
0.00 (0.00%)
May 20 2024 - Closed
Delayed by 15 minutes

Advanced Proteome Therap... (CE) Financial Summary

The current APTCF market cap is 8.23k. The company's latest EPS is USD 0.0185 and P/E is 0.00.

Year End July 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 350k0000
Operating Income -820k-936k-432k-507k-705k
Net Income -745k-333k-451k-1.83M759k
Year End July 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 184k167k20k897k636k
Total Liabilities 1.08M1.08M1.4M2.96M1.49M
Total Equity -896k-914k-1.38M-2.06M-851k

Cash Flow

Year End July 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -1.21M-685k-467k-545k-693k
Investing N/A -1,000 N/A -50k-14k
Financing 1.21M683k337k1.42M429k
Market Cap 8.23k
Price to Earnings Ratio 0.00
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 41.13M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 0.00%
52 Week High 0.0002
52 Week Low 0.0002
Spread (Intraday) 0 (0%)

Company Info

Company Name Advanced Proteome Therapeutics Corporation (CE)
Address 104 – 8337 eastlake drive
burnaby, british columbia V5A 4W2
Website https://www.advancedproteome.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock